4/20
08:00 am
phat
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
Low
Report
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
4/6
08:15 am
phat
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
4/6
08:00 am
phat
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Low
Report
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
3/27
08:36 am
phat
Phathom Pharmaceuticals (PHAT) was upgraded by Barclays PLC from "equal weight" to "overweight". They now have a $18.00 price target on the stock, up from $16.00.
Low
Report
Phathom Pharmaceuticals (PHAT) was upgraded by Barclays PLC from "equal weight" to "overweight". They now have a $18.00 price target on the stock, up from $16.00.
3/11
06:06 pm
phat
Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Medium
Report
Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/1
04:40 am
phat
Guggenheim Raises PT on Phathom Pharmaceuticals (PHAT) to $25 From $20, Here's Why [Yahoo! Finance]
High
Report
Guggenheim Raises PT on Phathom Pharmaceuticals (PHAT) to $25 From $20, Here's Why [Yahoo! Finance]
2/28
09:03 am
phat
Phathom Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
High
Report
Phathom Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/27
07:03 pm
phat
Why Phathom Pharmaceuticals (PHAT) Is Up 13.2% After Guiding To 2026 Operating Profitability And Narrower Losses [Yahoo! Finance]
High
Report
Why Phathom Pharmaceuticals (PHAT) Is Up 13.2% After Guiding To 2026 Operating Profitability And Narrower Losses [Yahoo! Finance]
2/27
10:58 am
phat
Phathom Pharmaceuticals (PHAT) had its price target raised by Guggenheim from $20.00 to $25.00. They now have a "buy" rating on the stock.
Low
Report
Phathom Pharmaceuticals (PHAT) had its price target raised by Guggenheim from $20.00 to $25.00. They now have a "buy" rating on the stock.
2/26
03:10 pm
phat
Phathom Pharmaceuticals (PHAT) was given a new $28.00 price target by Stifel Nicolaus.
Low
Report
Phathom Pharmaceuticals (PHAT) was given a new $28.00 price target by Stifel Nicolaus.
2/26
07:32 am
phat
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance [Yahoo! Finance]
Low
Report
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance [Yahoo! Finance]
2/26
07:00 am
phat
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Medium
Report
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
2/23
08:25 am
phat
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/23
08:00 am
phat
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Low
Report
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
2/17
08:21 am
phat
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026 [Yahoo! Finance]
Medium
Report
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026 [Yahoo! Finance]
2/17
08:00 am
phat
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
Medium
Report
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
2/5
09:27 am
phat
Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026 [Yahoo! Finance]
Medium
Report
Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026 [Yahoo! Finance]
2/5
08:00 am
phat
Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
Medium
Report
Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
1/22
05:41 pm
phat
Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
Medium
Report
Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]